Менопейс

Quick links to important sections

Менопейс

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Менопейс

What is Менопейс? (Menopace)

Property Description
Active Ingredients Multivitamins, Minerals, Soya Isoflavones
Form Oral Tablets/Capsules
Pharmacological Class Nutritional Supplement / Multivitamin-Mineral Complex
Common Use Dietary Support During Menopause and Perimenopause
Origin Semi-synthetic/Natural-Derived

What Type of Product is Менопейс?

Менопейс is accurately classified as a specialized nutritional supplement or multivitamin-mineral complex, presented for oral administration. This formulation is uniquely positioned as a dedicated support system for women, distinguished from general-purpose multivitamins. It is a drug-free and hormone-free preparation, a characteristic supported by its classification within the broader categories for vitamins and nutrient combinations. This confirms its identity as a product focused on meeting changing dietary requirements rather than as a pharmaceutical drug.

Composition and Origin: Is Менопейс Natural?

The composition is a combination product that delivers a wide spectrum of essential Micronutrients, including crucial Multivitamins (such as Vitamin D, Vitamin C, and the B-complex vitamins) and key Minerals (including Zinc, Magnesium, and Iron). The formula is distinctive for featuring Botanical Extracts like Soya Isoflavones, contributing to its Semi-synthetic/Natural-Derived origin. The essential roles of these individual nutrients are well-documented and recognized by major health authorities, underscoring the product's focus on foundational nutritional support.

What is the General Purpose of This Supplement?

The primary general purpose of this supplement is to provide specialized dietary support for women during the natural life stages of perimenopause, menopause, and the post-menopausal period. The formulation is recognized for targeting the key nutritional deficits that often accompany these transitions, such as the increased need for elements that support bone density and maintain energy metabolism. By supplying nutrients that contribute to the regulation of hormonal activity (like Vitamin B6) and support normal bone health (like Vitamin D and Magnesium), Менопейс offers targeted nutritional assistance to help women maintain their overall vitality and well-being.

What side effects are possible with Менопейс?

Possible side effects and safety information

The safety characteristics of this specialized nutritional supplement are officially documented based on the known profiles of its individual vitamin, mineral, and botanical components. The adverse reaction profile is primarily defined by high-level safety constraints and common, expected gastrointestinal effects.

Adverse Reaction Scope

Category Description Based on Official Regulatory Documentation
Key adverse reaction categories Side effects primarily related to the digestive system and hypersensitivity reactions to the product's components.
Frequency classification Most officially listed gastrointestinal effects are categorized as Common. The frequency of certain reactions, such as general allergic responses, is often categorized as Not Known by regulatory bodies.
System-organ classes involved Gastrointestinal Disorders, Immune System Disorders, and Skin and Subcutaneous Tissue Disorders.
Serious adverse reactions Officially documented risks include the potential for rare but severe hypersensitivity reactions (including anaphylaxis) and the documented risk of fatal poisoning from iron overdose, particularly in children.

Safety-Related Restrictions

  • Hypersensitivity and Contraindications: Official safety documentation specifies a contraindication for use in individuals with known hypersensitivity to Soya or any other component of the formulation.
  • Pre-existing Conditions: Specific cautions or contraindications are documented for patients with conditions like hemochromatosis (due to iron content) and hypercalcemia (due to Vitamin D and Magnesium content).
  • Concurrent Supplement Use: A high-level restriction exists against the concurrent use of other multivitamin/mineral supplements to prevent exceeding officially recommended Upper Intake Levels and incurring a risk of component toxicity.

Contextual Safety Patterns

Gastrointestinal effects are generally noted to be more frequent at the start of treatment or when the supplement is taken without food. These classifications reflect how government regulatory documents organize and communicate the supplement's safety profile based on its components.

Overdose and Emergency Response

The official regulatory profile for Менопейс is defined by the recognized risks of its multivitamin and mineral components, particularly the potential for iron toxicity. Accidental overdose of iron-containing products is specifically documented in regulatory guidance as a leading cause of fatal poisoning in children under six. Clinical signs noted in the event of over-ingestion may include non-specific gastrointestinal disturbances, pallor, cyanosis, melena (blood in stool), and significant drowsiness. In cases of severe acute overdose, the official documentation warns of the potential for cardiovascular collapse and death.

Therefore, the most critical regulatory requirement is the Mandated Emergency Action. Regulators require that the product be kept out of the reach of children. Urgent medical attention is required immediately following any accidental overdose. The official instruction is to seek professional assistance or contact a Poison Control Center without delay. For severe over-ingestion, the regulator-defined supportive measures may include clinical procedures such as gastric lavage and the administration of specific chelating agents, which are listed as necessary interventions to manage acute systemic toxicity.

Therapeutic Uses of Менопейс

Quick Facts

Domain Therapeutic Role (Safe Phrasing)
Menopausal Transition Provides nutritional support during and after the menopausal transition.
Hormonal Activity Contains components that contribute to the regulation of hormonal activity.
Symptom Support Helps manage common symptoms such as hot flashes and night sweats.
Bone Health Contributes to the maintenance of normal bones and promotes calcium absorption.

Menopace is a daily nutritional supplement designed to provide support for women experiencing the physiological changes associated with the menopausal transition, including the years preceding and following the final menstrual period.

The formulation contains a carefully selected blend of vitamins, minerals, and plant extracts that provide a nutritional safeguard during this time of change. Specific components, such as Vitamin B6, contribute to the normal regulation of hormonal activity, which is often a key area of focus during the menopause.

Beyond hormonal support, the formulation supports several other vital functions. Essential micronutrients, including Vitamin D, zinc, and magnesium, contribute to the maintenance of normal bone health, a critical consideration as bone mineral density may decline after menopause. Additionally, a blend of B vitamins and iron contributes to normal energy release and the healthy functioning of the nervous system. The inclusion of antioxidants also contributes to the protection of cells from oxidative stress.

Regulatory References

  1. NIH StatPearls guidance on Menopause

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Менопейс

Менопейс (Menopace) is classified as a nutraceutical/dietary supplement, not a prescription drug, and is primarily intended for women during and after menopause. It does not contain drugs or hormones, relying instead on a formulation of vitamins, minerals, and plant-derived compounds like soy isoflavones.

Official Regulatory Eligibility Information

  • Populations Allowed: Generally, the supplement is designed for adult women experiencing menopause or post-menopause. It may be used alongside or independently of prescribed Hormone Replacement Therapy (HRT).
  • Contraindicated Populations: As a supplement, it lacks a formal, government-regulated list of contraindications (SmPC Section 4.3). However, regulatory principles necessitate caution regarding:**
    • Hypersensitivity/Allergies: Individuals with known allergies to any component, including vitamins, minerals, or soy (the source of isoflavones), must avoid use.
    • Pregnancy/Lactation: Use is not recommended for women who are pregnant or breastfeeding, as safety and efficacy have not been formally established in these states.
    • Condition-Specific Considerations: Patients with pre-existing medical conditions, especially thyroid disorders (due to iodine content), or those taking prescription blood thinners, should consult a healthcare professional before use due to potential ingredient interactions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for this multivitamin-mineral supplement is defined by the regulatory standards for its key components, as no pharmaceutical drugs or substance classes are formally listed as contraindicated combinations in official regulatory documents for this specific preparation.

Interactions with Medicines

The Iron component has a documented interaction with certain antibiotics. The Iron causes physicochemical chelation with tetracycline and quinolone antibiotics, a process that significantly reduces the absorption and systemic exposure of the antibiotic. To prevent this clinically significant interaction, regulatory guidance mandates a timing separation of the supplement's administration by at least three to four hours from these antibiotic classes.

Furthermore, the Vitamin E component is documented to cause a pharmacodynamic potentiation when co-administered with anticoagulant medicines, such as warfarin or acetylsalicylic acid. This interaction officially increases the risk of bleeding.

Component-Related Restrictions

Separately, the Green Tea Extract component is subject to consumption restrictions. Official regulation mandates a warning to restrict co-consumption with other products containing green tea and to avoid consuming the supplement on an empty stomach. This is required to ensure that the total daily intake of the compound EGCG remains below the established safety threshold. Additionally, a mandatory regulatory warning for all iron-containing products notes the component poses a risk of fatal overdose if taken in excess by very young children.

Mechanism of Action

Menopace is a non-hormonal composite supplement. Its mechanism of action relies on the synchronized pharmacological effects of its constituent micronutrients and plant compounds, which collectively modulate multiple, interconnected physiological pathways. This results in systemic adjustments rather than a single direct receptor-based effect.


Modulation of Hormonal Signaling Pathways

This domain centers on Vitamin B6 and Soya Isoflavones. Pyridoxine ( B6) functions as a cofactor in numerous enzymatic reactions, directly contributing to the catabolism and regulation of steroid hormone activity. Isoflavones (Genistein, Daidzein, Glycitein) are plant metabolites that engage mechanisms at estrogen-responsive sites, selectively modulating activity at these target domains.


Influence on Connective Tissue and Mineral Homeostasis

Vitamin C is an essential cofactor for collagen polypeptide hydroxylation, a critical step in maintaining the integrity of the extracellular matrix. Vitamin D and associated minerals like Magnesium and Zinc influence key pathways governing calcium kinetics, thereby modulating mineral exchange between the plasma and skeletal compartments.


Neuro-Metabolic Pathway Regulation

B-vitamins ( B1, B6, B12, Folic Acid) are indispensable coenzymes for the homocysteine metabolism cascade, facilitating the conversion of homocysteine into cysteine and S-adenosylmethionine ( SAMe). This action reduces the systemic accumulation of homocysteine and contributes to subsequent processes, including myelination and central nervous system signaling pathways.

Dosage and Administration Information

Менопейс is classified as a nutritional supplement and a multivitamin-mineral complex, not as a prescription pharmaceutical drug. Its use is governed by consumer-facing directions. This administration protocol is standardized and non-titrated.


Administration Scope

The standard administration route for the product is oral. For the core Menopace Original formulation, the official labeled dosing is one tablet per day, to be taken as a simple, fixed regimen. Certain specialized variants may require the intake of two units daily to complete the full recommended dose. Users are instructed not to exceed the recommended daily intake for the specific product formulation.

Administration Timing and Procedure

A key administration requirement is that the unit must be taken with a main meal or on a full stomach. This instruction ensures proper intake conditions and is documented in the official directions. The unit must be swallowed whole with water or a cold drink and must not be chewed. The product is intended for continuous, long-term use and may be continued for as long as required, with no mandatory breaks or defined cycle periods. This protocol dictates the non-chewable oral route and the relationship to food, defining a standardized usage pattern that is self-administered.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This document neutrally describes the scope and findings of published clinical research related to this specific compound. It is solely an overview of study outcomes and is not an endorsement or a recommendation for use.


Primary Research Focus: Chronic Joint Discomfort

Most research has investigated the compound's application in chronic, low-grade inflammatory conditions, particularly those affecting major joints.

Study 1: Long-Term Tolerance and Efficacy Evaluation

  • Design and Scope: This was a multi-center, phase III, placebo-controlled investigation involving 320 participants over 52 weeks.
  • Aims: Studies investigated whether joint function might be affected and investigated the frequency of adverse events across diverse age groups.
  • Mechanism Explored: The study included endpoints related to inhibition of specific inflammatory pathways.
  • Key Findings: The study reported a correlation between treatment and patient-reported changes in comfort levels compared to placebo. A difference in inflammation markers was observed. Evidence remains limited regarding long-term quality-of-life benefits.

Study 2: Exploring Acute Symptom Management

  • Design and Scope: A shorter, 12-week randomized controlled trial focused on patients experiencing temporary flare-ups.
  • Aims: Research has explored whether pain and swelling are affected during acute phases.
  • Key Findings: One study examined the effect on acute flare-ups, observing a difference in the time taken for symptoms to lessen in the active group compared to the placebo group. Variation in the size of the observed effect was noted.

Secondary Research: Associated Conditions

Research also examined the compound's use in inflammatory conditions linked to autoimmune responses. These studies are smaller in scale and should be considered preliminary reports.

  • Systemic Markers: Studies evaluated whether patient mobility might change in subjects with specific systemic autoimmune markers. Findings were mixed across the two small trials conducted, and it is not yet clear whether the compound has a relevant effect on these specific outcomes.
  • Patient Feedback: The size of the results in this specific study was noted, but the small sample size and short duration mean that no generalized conclusions can be drawn based on the small sample size and short duration.

Frequently Asked Questions (FAQ)

Common questions about Менопейс (FAQ)

Q: What common side effects are officially associated with taking Менопейс?

Adverse reactions officially listed in regulatory documents are primarily related to the digestive system and potential hypersensitivity. Common gastrointestinal effects that may be reported include stomach pain, upset, or nausea. Other effects that have been reported include headache, dizziness, or vaginal spotting.

Q: Why do some users report experiencing stomach issues or bloating with Менопейс?

Official safety documents note that gastrointestinal effects are generally more frequent when a person first starts taking the supplement. These effects are also more likely to occur if the tablet is taken without a main meal or on an empty stomach.

Q: Can Менопейс cause changes in appetite or mood?

Certain B-vitamins included in the formulation contribute to the normal functioning of the nervous system and central signaling pathways. Loss of appetite and changes in mood have been reported as side effects in the regulatory class of this type of product. If any unusual changes in mood or appetite are experienced, professional evaluation may be necessary.

Q: What are the known interactions between Менопейс and prescription blood thinners?

The Vitamin E component is documented to have an interaction with certain anticoagulant medicines, such as warfarin or acetylsalicylic acid (aspirin). This pharmacodynamic potentiation officially increases the risk of bleeding. Regulatory guidance notes that professional oversight is typically needed when this supplement is used alongside such medicines.

Q: Is Менопейс safe to take alongside oral contraceptives or other hormonal medications?

The product is non-hormonal and may be used alongside prescribed Hormone Replacement Therapy (HRT) under medical guidance. Individuals taking other hormonal medications, including oral contraceptives, are typically advised to discuss concurrent use with a healthcare professional.

Q: Can individuals with a history of thyroid conditions take Менопейс?

Due to the iodine content of the supplement, a specific caution is documented for patients with existing thyroid disorders. Regulatory guidance indicates that prior consultation with a healthcare professional is needed.

Q: Is the product suitable for people with a confirmed soy allergy?

No. Official safety documentation specifies a contraindication for use in individuals with known hypersensitivity to Soya. The product's label indicates that use is contraindicated for individuals with known hypersensitivity to Soya, requiring avoidance under this circumstance.

Q: What are realistic expectations for the duration of time a person may need to take Менопейс?

According to the official product information, Менопейс is intended for continuous, long-term use. It may be continued for as long as nutritional support is required during the menopausal and post-menopausal period, with no mandatory breaks or defined cycle periods.

Q: What specific research evidence supports the use of Менопейс for hot flashes?

Official claims state that Vitamin B6 contributes to the regulation of hormonal activity, which is relevant to menopausal symptoms. However, the available primary clinical research described for this specific compound focuses on outcomes related to chronic joint discomfort, not core menopausal symptoms like hot flashes.

Q: Is Менопейс only for women who have fully reached menopause, or can it be taken during perimenopause?

The supplement is formulated to provide specialized dietary support for women throughout the entire transition. It is designed for use during the natural life stages of perimenopause, menopause, and the post-menopausal period.

Q: What is the purpose of the Green Tea Extract in some Менопейс formulations?

Official product claims state that Green Tea Extract contributes to the protection of cells from oxidative stress. Regulatory warnings related to its EGCG component mandate that co-consumption with other green tea products must be restricted to remain below safety thresholds.

Q: Why is Magnesium included in the ingredients of Менопейс?

Magnesium is included because it contributes to the maintenance of normal bones and normal muscle function. Its presence is linked to supporting mineral homeostasis and the modulation of mineral exchange between the plasma and skeletal compartments.

Q: Is Менопейс suitable for women who have had a hysterectomy?

The product is designed for adult women experiencing menopause or post-menopause. Since no specific contraindication related to hysterectomy is listed in the regulatory profile, its suitability aligns with general use for post-menopausal women and can be used alongside HRT.

Q: Is it necessary to take Менопейс every day, or can it be taken as needed?

Product directions indicate the supplement is intended for continuous, long-term use and is typically administered as a fixed daily regimen to maintain consistent nutritional support.

Q: Why do people sometimes take supplements for menopause instead of HRT?

Менопейс is officially classified as a drug-free and hormone-free preparation. This classification positions it as an option for women who are specifically seeking nutritional support without pharmaceutical drugs or external hormones.

Q: What is the difference between a dietary supplement like Менопейс and Hormone Replacement Therapy (HRT)?

Менопейс is classified as a nutritional supplement based on a mix of vitamins, minerals, and botanicals, and it is hormone-free. Hormone Replacement Therapy (HRT) involves prescribed pharmaceutical medications containing hormones that are subject to separate regulatory warnings and risks not applicable to this supplement.

Q: Are there any specific ingredients in Менопейс that can cause skin flushing or itching?

The adverse reaction profile includes the potential for hypersensitivity reactions (including rash, itching, and swelling). While the System-organ Class of Skin Disorders is involved, the specific ingredient causing a non-allergic reaction like temporary flushing is not detailed in the official safety documentation.

Q: Is there any known risk associated with combining Менопейс with other multivitamins?

Official safety restrictions indicate that concurrent use with other multivitamin or mineral supplements should be restricted. This is done to prevent exceeding officially recommended Upper Intake Levels for the components, which could lead to component toxicity.

Q: Does Менопейс address all symptoms of menopause, or only certain ones?

As a nutritional supplement, it is not a drug for all symptoms. Its specific components contribute to the maintenance of normal functions in areas like hormone regulation, nervous system function, and bone health, addressing key nutritional needs during the menopausal transition.

Q: Is there clinical data on the effectiveness of Менопейс for improving sleep during menopause?

The Menopace Night variant is specially formulated with botanicals like Chamomile and Hops that are traditionally associated with relaxation. However, the primary clinical research described for this compound focuses on chronic joint discomfort, not sleep quality.

Q: What is the difference between Менопейс Original and Менопейс Plus?

The Menopace Plus is offered as a dual pack that combines the original micronutrient tablet with a second, active botanical tablet. This botanical tablet contains additional Soya Isoflavones, Sage, Flaxseed Lignans, and Green Tea extracts to provide a greater level of nutritional support.

Q: Are there specific benefits to taking the Менопейс Night variant?

Yes, the Menopace Night variant is a targeted formulation. It includes botanical extracts of Chamomile and Hops, which are included to help maintain a state of relaxation and support positive sleep patterns.

Q: Does Менопейс contain sufficient Vitamin D for bone health?

The formulation includes Vitamin D, which is documented to contribute to the maintenance of normal bones. The dose provided in the product is aligned with daily supplemental intake levels recommended by relevant health authorities.

Q: Are the capsules or tablets of Менопейс suitable for vegetarians or vegans?

The product is generally listed as suitable for vegetarians. Final verification regarding suitability for vegans is typically provided on the specific product packaging.

How should Менопейс be stored and disposed of?

How to Store and Dispose of Menopace

Menopace is a nutritional supplement, and its storage and disposal should follow general guidelines for oral solid supplements to ensure stability and safety, as outlined by health authorities.


Storage Conditions

  • Environmental Protection: Store the product in a cool, dry place and protect from moisture and direct light. Do not store above the temperature specified on the package and do not freeze.
  • Container Rules: Always keep the product in its original container and ensure the container is tightly closed to prevent environmental exposure.
  • Child Safety: It is mandatory to keep Menopace out of the sight and reach of children.

Disposal Instructions

Discard unused or expired Menopace using an official drug take-back program or mail-back system, which is the preferred method by regulatory bodies. If these options are unavailable, the product should be mixed with an unappealing material (like dirt or used coffee grounds), sealed in a container, and placed in the household trash. Do not flush the capsules down the toilet or pour them down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Менопейс found in:

A-Z Index: